What happens when you take warfarin with ginkgo?
Warfarin is a vitamin K antagonist. It slows the liver's production of clotting factors II, VII, IX, and X, so blood takes longer to clot. The international normalised ratio (INR) is the lab number used to keep that effect inside a safe window, typically 2.0-3.0 for atrial fibrillation and most venous clots.
Ginkgo biloba leaf extract works through a completely different mechanism. Its terpene lactones (ginkgolides A, B, C and bilobalide) are potent inhibitors of platelet-activating factor (PAF). When PAF is blocked, platelets are less likely to clump together at a site of vessel injury. On its own, this effect is modest and rarely causes problems in a healthy person. Stacked on top of warfarin, however, you now have two different brakes on the clotting system at the same time: one on the coagulation cascade (warfarin) and one on platelets (ginkgo).
A 2025 PLOS One analysis of 2,647 prescriptions reported that patients taking ginkgo together with warfarin had a measurably higher rate of bleeding events and abnormal coagulation results compared with warfarin alone. Older case reports describe spontaneous intracranial bleeding, subdural haematoma, and bleeding from the eye in patients who added a ginkgo product to anticoagulant therapy.
Why is this important?
The INR test does not measure platelet function. That is the key point clinicians worry about with ginkgo. Your INR can sit comfortably at 2.5 while ginkgo is silently inhibiting platelets in the background, so a routine blood test will not warn you. The first signal can be a bruise that will not stop, a nosebleed that takes an hour to clip off, or, in the worst case, a bleed inside the brain or gut.
The risk is not equal across all ginkgo products. Standardised pharmaceutical-grade extracts such as EGb 761 have been studied most and show the weakest effect in healthy volunteers. Cheap, unstandardised supplements vary widely in ginkgolide content and may be more likely to cause trouble. Because supplement labels are not always accurate, you cannot reliably tell from the bottle which kind you are taking.
Older adults, people with prior gastrointestinal bleeds, people on aspirin or an NSAID at the same time, and people with poorly controlled blood pressure carry the highest absolute risk. The same dose that is harmless in a 40-year-old can be the tipping point for a 78-year-old on warfarin, aspirin, and an SSRI.
What should you do?
If you are already on warfarin, the safest move is to avoid ginkgo supplements entirely. The clinical benefit of ginkgo for memory or circulation is modest at best, and the downside of an unexpected bleed is severe.
If you choose to continue ginkgo, do not start, stop, or change the dose without first telling the clinician who manages your warfarin. Ask for an INR check within 1-2 weeks of any change, and remember that a normal INR does not rule out an interaction because platelet effects are invisible to that test.
Stop ginkgo and call your anticoagulation clinic the same day if you notice any of the following: a nosebleed lasting more than 10 minutes, bleeding gums when brushing, pink or red urine, black or tarry stools, vomiting that looks like coffee grounds, large new bruises, a severe headache, or any new weakness, numbness, or change in vision. Bleeding inside the skull is the most feared complication and time matters.
Many surgeons and dentists ask patients to stop ginkgo at least 7-14 days before an elective procedure. Coordinate that with the team managing your warfarin so you do not get caught between two sets of bridging instructions.
Which specific products are affected?
The warning applies to oral ginkgo biloba leaf extracts in any form: standardised extracts such as EGb 761 (sold under brand names including Tebonin, Tanakan, Rokan), generic ginkgo capsules and tablets, liquid tinctures, and ginkgo-containing memory or focus blends. Many over-the-counter brain-health stacks, ginseng-and-ginkgo combinations, and traditional Chinese medicine formulas include ginkgo even when it is not the headline ingredient.
Edible ginkgo nuts (the seed, eaten in small culinary amounts in some Asian cuisines) are not the same product as the leaf extract and have not been linked to warfarin interaction at normal food doses. Topical ginkgo (in cosmetic creams) is also a different question; it is not believed to cause systemic effects but data are limited.
The bottom line
Warfarin and ginkgo work through different mechanisms, but both reduce the body's ability to stop bleeding. The combination has been linked to a measurable increase in bleeding events. Because ginkgo's effect is on platelets, your INR can look normal while your real bleeding risk is climbing. The safest choice is to avoid ginkgo while you are on warfarin. If you take it anyway, tell your anticoagulation team, get an INR check after any change, and treat any unusual bleeding as urgent.